Free Trial
→ Crypto’s crashing…but we’re still profiting (From Crypto Swap Profits) (Ad) Buy GHRS Stock  Free GHRS Stock Alerts

GH Research (GHRS) Financials

GH Research logo
$9.50 0.00 (0.00%)
As of 04/24/2025 04:00 PM Eastern
Compare
Annual Income Statements for GH Research

Annual Income Statements for GH Research

This table shows GH Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -0.31 -0.45 -9.20 -22 -36 -39
Consolidated Net Income / (Loss)		 -0.31 -0.45 -9.20 -22 -36 -39
Net Income / (Loss) Continuing Operations		 -0.31 -0.45 -9.20 -22 -36 -39
Total Pre-Tax Income 		-0.31 -0.45 -9.20 -22 -36 -39
Total Operating Income		 -0.31 -0.45 -15 -31 -41 -50
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 0.31 0.45 15 31 41 50
Selling, General & Admin Expense		 0.01 0.11 6.55 10 11 15
Research & Development Expense		 0.30 0.34 8.55 20 30 35
Total Other Income / (Expense), net		 0.00 0.00 5.90 8.22 5.63 11
Interest Expense		 - - 0.01 0.12 0.72 0.72
Interest & Investment Income		 - - 0.00 1.17 8.98 9.87
Other Income / (Expense), net		 0.00 0.00 5.91 7.18 -2.62 2.13
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75)
Weighted Average Basic Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M
Diluted Earnings per Share		 ($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75)
Weighted Average Diluted Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M
Weighted Average Basic & Diluted Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M

Quarterly Income Statements for GH Research

No quarterly income statements for GH Research are available.

Annual Cash Flow Statements for GH Research

This table details how cash moves in and out of GH Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 0.51 5.17 271 -111 -88 23
Net Cash From Operating Activities		 -0.29 -0.33 -15 -26 -33 22
Net Cash From Continuing Operating Activities		 -0.29 -0.33 -15 -25 -26 22
Net Income / (Loss) Continuing Operations		 -0.31 -0.45 -9.20 -22 -36 -39
Consolidated Net Income / (Loss)		 -0.31 -0.45 -9.20 -22 -36 -39
Depreciation Expense		 0.00 0.00 0.02 0.05 0.32 0.32
Non-Cash Adjustments To Reconcile Net Income		 0.02 0.12 -6.09 -3.22 4.91 61
Net Cash From Investing Activities		 0.00 0.00 -0.10 -85 -54 -0.05
Net Cash From Continuing Investing Activities		 0.00 0.00 -0.10 -85 -54 -0.05
Purchase of Property, Plant & Equipment		 0.00 0.00 -0.10 -0.07 -0.10 -0.05
Net Cash From Financing Activities		 0.80 5.50 286 0.00 -0.20 0.00
Net Cash From Continuing Financing Activities		 0.80 5.50 286 0.00 -0.20 0.00

Quarterly Cash Flow Statements for GH Research

No quarterly cash flow statements for GH Research are available.

Annual Balance Sheets for GH Research

This table presents GH Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets		 5.91 280 254 226 188
Total Current Assets		 5.91 280 169 164 154
Cash & Equivalents		 5.90 277 166 78 101
Other Current Assets		 0.02 3.07 2.59 2.53 4.90
Other Current Nonoperating Assets		 - - 0.00 56 19
Plant, Property, & Equipment, net		 0.00 0.00 0.10 1.07 0.75
Plant, Property & Equipment, gross		 0.00 - 0.10 1.07 0.75
Total Noncurrent Assets		 0.00 0.08 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 5.91 280 254 226 188
Total Liabilities		 0.25 2.75 4.55 7.33 9.32
Total Current Liabilities		 0.25 2.75 4.55 6.70 8.95
Accounts Payable		 0.00 0.88 1.87 3.49 3.74
Other Current Liabilities		 0.25 1.87 2.68 3.21 5.21
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.63 0.37
Capital Lease Obligations		 - - 0.00 0.63 0.37
Total Equity & Noncontrolling Interests		 5.67 277 250 219 179
Total Preferred & Common Equity		 5.67 277 250 219 179
Total Common Equity		 5.67 277 250 219 179
Common Stock		 6.30 1.30 293 293 293
Retained Earnings		 -0.84 -10 -32 -68 -106
Other Equity Adjustments		 0.20 286 -10 -5.86 -7.37

Quarterly Balance Sheets for GH Research

No quarterly balance sheets for GH Research are available.

Annual Metrics and Ratios for GH Research

This table displays calculated financial ratios and metrics derived from GH Research's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% -43.87% -1,956.95% -154.32% -83.47% -11.83%
EBIT Growth		 0.00% -43.87% -1,961.21% -154.30% -87.54% -9.90%
NOPAT Growth		 0.00% -43.87% -3,285.65% -102.34% -34.92% -22.05%
Net Income Growth		 0.00% -43.87% -1,963.23% -144.03% -58.47% -9.48%
EPS Growth		 0.00% -45.45% -1,212.50% -104.76% -58.14% -10.29%
Operating Cash Flow Growth		 0.00% -14.19% -4,531.21% -71.43% -27.24% 167.22%
Free Cash Flow Firm Growth		 0.00% 0.00% -13,359.13% -70.80% -44.39% -26.80%
Invested Capital Growth		 0.00% 0.00% 274.24% -566.92% -66.56% -6.48%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.10% 96.06% 81.17% 80.86%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -7.87% -6.51% -8.52% -15.18% -19.58%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -2,806.52% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -7.87% -6.51% -8.52% -15.18% -19.58%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -7.87% -3.32% -8.99% -16.25% -21.77%
Net Operating Profit after Tax (NOPAT)		 -0.22 -0.31 -11 -21 -29 -35
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% -4.54% 0.97% -0.40% -2.84% -1.85%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -8.56% -13.14% -19.64%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -0.31 -0.45 -9.19 -23 -44 -48
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.31 -0.45 -9.17 -23 -43 -48
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 28.24 0.84 2.02 1.38 2.04
Price to Tangible Book Value (P/TBV)		 0.00 28.24 0.84 2.02 1.38 2.04
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 11.77
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -1.04 -1.00 -1.00 -1.01 -1.02
Leverage Ratio		 0.00 1.04 1.01 1.01 1.03 1.04
Compound Leverage Factor		 0.00 1.04 1.01 0.97 0.83 0.84
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.29% 0.21%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.29% 0.21%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 100.00% 100.00% 99.71% 99.79%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.01 -0.01
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 1.82 2.10
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.01 -0.01
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.02 -0.01
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 2.70 2.85
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.02 -0.01
Altman Z-Score		 0.00 390.95 51.95 67.03 24.47 22.73
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 24.03 101.80 37.07 24.49 17.23
Quick Ratio		 0.00 23.96 100.68 36.51 11.70 11.26
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -0.08 -11 -19 -28 -35
Operating Cash Flow to CapEx		 0.00% 0.00% -14,695.19% -39,102.99% -33,336.00% 45,728.57%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -1,244.22 -155.49 -38.20 -48.84
Operating Cash Flow to Interest Expense		 0.00 0.00 -1,698.11 -213.00 -46.11 31.25
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -1,709.67 -213.54 -46.25 31.18
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 -0.23 0.40 -1.86 -3.10 -3.30
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 -0.23 0.63 -2.26 -1.24 -0.20
Enterprise Value (EV)		 0.00 154 -43 340 224 264
Market Capitalization		 160 160 233 506 302 364
Book Value per Share		 $0.00 $0.57 $5.33 $4.80 $4.21 $3.44
Tangible Book Value per Share		 $0.00 $0.57 $5.33 $4.80 $4.21 $3.44
Total Capital		 0.00 5.67 277 250 220 179
Total Debt		 0.00 0.00 0.00 0.00 0.63 0.37
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.63 0.37
Net Debt		 0.00 -5.90 -277 -166 -78 -100
Capital Expenditures (CapEx)		 0.00 0.00 0.10 0.07 0.10 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.23 0.32 -1.96 79 44
Debt-free Net Working Capital (DFNWC)		 0.00 5.67 277 164 157 145
Net Working Capital (NWC)		 0.00 5.67 277 164 157 145
Net Nonoperating Expense (NNE)		 0.09 0.13 -1.37 1.07 6.73 3.74
Net Nonoperating Obligations (NNO)		 0.00 -5.90 -277 -252 -222 -182
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.02 0.05 1.04 0.32
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.22 -0.31 -11 -21 -29 -35
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 -1,021.44 -190.07 -60.64 -67.20
NOPAT to Interest Expense		 0.00 0.00 -1,174.44 -173.88 -39.91 -49.12
EBIT Less CapEx to Interest Expense		 0.00 0.00 -1,033.00 -190.61 -60.78 -67.27
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -1,186.00 -174.43 -40.05 -49.19
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -247.26% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for GH Research

No quarterly metrics and ratios for GH Research are available.

Frequently Asked Questions About GH Research's Financials

When does GH Research's financial year end?

According to the most recent income statement we have on file, GH Research's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has GH Research's net income changed over the last 5 years?

GH Research's net income appears to be on an upward trend, with a most recent value of -$38.96 million in 2024, rising from -$310 thousand in 2019. The previous period was -$35.59 million in 2023.

What is GH Research's operating income?
GH Research's total operating income in 2024 was -$50.31 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $50.31 million
How has GH Research revenue changed over the last 5 years?

Over the last 5 years, GH Research's total revenue changed from $0.00 in 2019 to $0.00 in 2024, a change of 0.0%.

How much debt does GH Research have?

GH Research's total liabilities were at $9.32 million at the end of 2024, a 27.1% increase from 2023, and a 3,689.4% increase since 2020.

How much cash does GH Research have?

In the past 4 years, GH Research's cash and equivalents has ranged from $5.90 million in 2020 to $276.78 million in 2021, and is currently $100.79 million as of their latest financial filing in 2024.

How has GH Research's book value per share changed over the last 5 years?

Over the last 5 years, GH Research's book value per share changed from 0.00 in 2019 to 3.44 in 2024, a change of 344.0%.


Related Companies

This page (NASDAQ:GHRS) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Trump purposefully forcing markets to crash…
Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...
Porter & Company | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Amazon Shocker
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...
Stansberry Research | Sponsored